MARVELL TECHNOLOGY, INC. (MRVL)
Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204
Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204
Alliance Resource Partners, L.P. Expands Oil & Gas Royalties Platform With $206 Million Acquisition
Ciena Announces Proposed Offering of Convertible Senior Notes
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
Brady Corporation Announces CEO Transition
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
Anfield Energy Provides Operational Update on Shootaring Canyon Uranium Mill License Renewal and Refurbishment
Bristol Myers Squibb - Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease